Muriel Cuendet - Search Results

Year	Number of Results
2002	5
2003	1
2004	11
2005	1
2006	5
2007	2
2008	2
2009	1
2010	2
2011	1
2012	3
2013	2
2014	7
2015	5
2016	10
2017	13
2018	9
2019	2
2020	3
2021	4
2022	5
2023	6
2024	0

1

Histone deacetylase-based dual targeted inhibition in multiple myeloma.

Ferro A, Pantazaka E, Athanassopoulos CM, Cuendet M. Ferro A, et al. Among authors: cuendet m. Med Res Rev. 2023 Nov;43(6):2177-2236. doi: 10.1002/med.21972. Epub 2023 May 16. Med Res Rev. 2023. PMID: 37191917 Review.

2

The Multiple Myeloma Landscape: Epigenetics and Non-Coding RNAs.

Coira IF, Rincón R, Cuendet M. Coira IF, et al. Among authors: cuendet m. Cancers (Basel). 2022 May 10;14(10):2348. doi: 10.3390/cancers14102348. Cancers (Basel). 2022. PMID: 35625953 Free PMC article. Review.

3

Entinostat-Bortezomib Hybrids against Multiple Myeloma.

Ferro A, Graikioti D, Gezer E, Athanassopoulos CM, Cuendet M. Ferro A, et al. Among authors: cuendet m. Molecules. 2023 Feb 2;28(3):1456. doi: 10.3390/molecules28031456. Molecules. 2023. PMID: 36771118 Free PMC article.

4

Targeting tumor-associated macrophages by anti-tumor Chinese materia medica.

Pu WL, Sun LK, Gao XM, Rüegg C, Cuendet M, Hottiger MO, Zhou K, Miao L, Zhang YS, Gebauer M. Pu WL, et al. Among authors: cuendet m. Chin J Integr Med. 2017 Oct;23(10):723-732. doi: 10.1007/s11655-017-2974-y. Epub 2017 Oct 8. Chin J Integr Med. 2017. PMID: 28988387 Review.

5

Natural inhibitors of carcinogenesis.

Kinghorn AD, Su BN, Jang DS, Chang LC, Lee D, Gu JQ, Carcache-Blanco EJ, Pawlus AD, Lee SK, Park EJ, Cuendet M, Gills JJ, Bhat K, Park HS, Mata-Greenwood E, Song LL, Jang M, Pezzuto JM. Kinghorn AD, et al. Among authors: cuendet m. Planta Med. 2004 Aug;70(8):691-705. doi: 10.1055/s-2004-827198. Planta Med. 2004. PMID: 15326546 Review.

6

Resveratrol as a circadian clock modulator: mechanisms of action and therapeutic applications.

Spaleniak W, Cuendet M. Spaleniak W, et al. Among authors: cuendet m. Mol Biol Rep. 2023 Jul;50(7):6159-6170. doi: 10.1007/s11033-023-08513-2. Epub 2023 May 25. Mol Biol Rep. 2023. PMID: 37231216 Free PMC article. Review.

7

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

Issa ME, Takhsha FS, Chirumamilla CS, Perez-Novo C, Vanden Berghe W, Cuendet M. Issa ME, et al. Among authors: cuendet m. Clin Epigenetics. 2017 Feb 10;9:17. doi: 10.1186/s13148-017-0319-5. eCollection 2017. Clin Epigenetics. 2017. PMID: 28203307 Free PMC article. Review.

8

Plants as a source of therapeutic and health products.

Christen P, Cuendet M. Christen P, et al. Among authors: cuendet m. Chimia (Aarau). 2012;66(5):320-3. doi: 10.2533/chimia.2012.320. Chimia (Aarau). 2012. PMID: 22867544 Free article. Review.

9

HDAC inhibitors: a 2013-2017 patent survey.

Faria Freitas M, Cuendet M, Bertrand P. Faria Freitas M, et al. Among authors: cuendet m. Expert Opin Ther Pat. 2018 Apr 19:1-17. doi: 10.1080/13543776.2018.1459568. Online ahead of print. Expert Opin Ther Pat. 2018. PMID: 29671355

10

HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?

Simões-Pires C, Zwick V, Nurisso A, Schenker E, Carrupt PA, Cuendet M. Simões-Pires C, et al. Among authors: cuendet m. Mol Neurodegener. 2013 Jan 29;8:7. doi: 10.1186/1750-1326-8-7. Mol Neurodegener. 2013. PMID: 23356410 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year